Effects of smoking cessation on hypoxia and its potential impact on radiation treatment effects in lung cancer patients

Strahlentherapie und Onkologie

Volumn 184, Issue 11, 2008, Pages 605-609

  Nieder, Carsten ^a,b,d   Bremnes, Roy M ^b,c  

^a Radiation Oncology Unit   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^d NORDLAND HOSPITAL   (Norway)

Author keywords

Lung cancer; Lung function; Radiotherapy; Smoking cessation

Indexed keywords

CANCER RADIOTHERAPY; CANCER SURVIVAL; HUMAN; HYPOXIA; LUNG FUNCTION; LUNG NON SMALL CELL CANCER; PNEUMONIA; PREVALENCE; REVIEW; SMOKING CESSATION; TREATMENT PLANNING;

HEALTH STATUS; HUMANS; LUNG NEOPLASMS; RESEARCH DESIGN; RETROSPECTIVE STUDIES; SMOKING; SMOKING CESSATION; TREATMENT OUTCOME;

EID: 56549123428     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-008-1877-4     Document Type: Review

References (36)

1. Baser S, Shannon VR, Eapen GA, et al. Smoking cessation after diagnosis of lung cancer is associated with a beneficial effect on performance status. Chest 2006;130:1784-90.
2. Bischof M, Debus J, Herfarth K, et al. Surgery and chemotherapy for small cell lung cancer in stages I-II with or without radiotherapy. Strahlenther Onkol 2007;183:679-84.
3. Bradley JD, Hope A, El Naqa I, et al. A nomogram to predict radiation pneumonitis, derived from a combined analysis of RTOG 9311 and institutional data. Int J Radiat Oncol Biol Phys 2007;69:985-92.
4. Buist AS, Sexton GJ, Nagy JM, Ross BB. The effect of smoking cessation and modification on lung function. Am Rev Respir Dis 1976;114:115-22.
5. Eschmann SM, Paulsen F, Reimold M, et al. Prognostic impact og hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy. J Nucl Med 2005;46:253-60.
6. Ernst-Stecken A, Lambrecht U, Mueller R, et al. Hypofractionated stereotactic radiotherapy for primary and secondary intrapulmonary tumors: first results of a phase I/II study. Strahlenther Onkol 2006;182:696-702.
7. Fox JL, Rosenzweig KE, Ostroff JS. The effect of smoking status on survival following radiation therapy for non-small cell lung cancer. Lung Cancer 2004;44:287-93.
8. Gagel B, Piroth M, Pinkawa M, et al. Gemcitabine concurrent with thoracic radiotherapy after induction chemotherapy with gemcitabine/vinorelbine in locally advanced non-small cell lung cancer: a phase I study. Strahlenther Onkol 2006;182:263-9.
9. Grau C, Horsman MR, Overgaard J. Influence of carboxyhemoglobin level on tumor growth, blood flow, and radiation response in an experimental model. Int J Radiat Oncol Biol Phys 1992;22:421-4.
10. Hernando ML, Marks LB, Bentel GC, et al. Radiation-induced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancer. Int J Radiat Oncol Biol Phys 2001;51:650-9.
11. Johnston-Early A, Cohen MH, Minna JD, et al. Smoking abstinence and small cell lung cancer survival: an association. JAMA 1980;244:2175-9.
12. Khuder SA, Mutgi AB. Effect of smoking cessation on major histologic types of lung cancer. Chest 2001;120:1577-83.
13. Klautke G, Sauer R, Fietkau R. Combined treatment modality in small cell lung cancer: the impact of radiotherapy on survival. Strahlenther Onkol 2008;184:61-6.
14. Lau SK, Boutros PC, Pintilie M, et al. Three-gene prognostic classifier for early-stage non small-cell lung cancer. J Clin Oncol 2007;25:5562-9.
15. Le QT, Chen E, Salim A, et al. An evaluation of tumor oxygenation and gene expression in patients with early stage non-small cell lung cancers. Clin Cancer Res 2006;12:1507-14.
16. Monson JM, Stark P, Reilly JJ, et al. Clinical radiation pneumonitis and radiographic changes after thoracic radiation therapy for lung carcinoma. Cancer 1998;82:842-50.
17. Movsas B, Moughan J, Komaki R, et al. Radiotherapy patterns of care study in lung carcinoma. J Clin Oncol 2003;21:4553-9.
18. Nakamura H, Haruki T, Adachi Y, et al. Smoking affects prognosis after lung cancer surgery. Surg Today 2008;38:227-31.
19. Ohashi T, Takeda A, Shigematsu N, et al. Differences in pulmonary function before vs. 1 year after hypofractionated stereotactic radiotherapy for small peripheral lung tumors. Int J Radiat Oncol Biol Phys 2005;62:1003-8.
20. Omori H, Nonami Y, Morimoto Y. Effect of smoking on FEV decline in a cross-sectional and longitudinal study of a large cohort of Japanese males. Respirology 2005;10:464-9.
21. Rades D, Setter C, Schild SE, Dunst J. Effect of smoking during radiotherapy, respiratory insufficiency, and haemoglobin levels on outcome in patients irradiated for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2008;71:1134-42.
22. Remy-Jardin M, Edme JL, Boulenguez C, et al. Longitudinal follow-up study of smoker's lung with thin-section CT in correlation with pulmonary function tests. Radiology 2002;222:261-70.
23. Sanderson Cox L, Patten CA, Ebbert JO, et al. Tobacco use outcomes among patients with lung cancer treated for nicotine dependence. J Clin Oncol 2002;20:3461-9.
24. Sanderson Cox L, Sloan JA, Patten CA, et al. Smoking behavior of 226 patients with diagnosis of stage IIIA/IIIB non-small cell lung cancer. Psychooncology 2002;11:472-8.
25. Sansores RH, Pare P, Abboud RT. Effect of smoking cessation on pulmonary carbon monoxide diffusing capacity and capillary blood volume. Am Rev Respir Dis 1992;146:959-64.
26. Sardari Nia P, Weyler J, Colpaert C, et al. Prognostic value of smoking status in operated non-small cell lung cancer. Lung Cancer 2005;47:351-9.
27. Sarihan S, Ercan I, Saran A, et al. Evaluation of infections in non-small cell lung cancer patients treated with radiotherapy. Cancer Detect Prev 2005;29:181-8.
28. Sarna L, Swann S, Langer C, et al. Clinically meaningful differences in patient-reported outcomes with Amifostine in combination with chemoradiation for locally advanced non-small-cell lung cancer: an analysis of RTOG 9801. Int J Radiat Oncol Biol Phys 2008;epub.
29. Semrau S, Bier A, Thierbach U, et al. 6-year experience of concurrent radiochemotherapy with vinorelbine plus a platinum compound in multimorbid or aged patients with inoperable non-small cell lung cancer. Strahlenther Onkol 2007;183:30-5.
30. Soejima K, Yamaguchi K, Kohda E, et al. Longitudinal follow-up study of smoking-induced lung density changes by high-resolution computed tomography. Am J Respir Crit Care Med 2000;161:1264-73.
31. Tsao AS, Liu D, Lee JJ, et al. Smoking affects treatment outcome in patients with advanced nonsmall cell lung cancer. Cancer 2006;106:2428-36.
32. Tucker MA, Murray N, Shaw EG, et al. Second primary cancers related to smoking and treatment of small-cell lung cancer. J Natl Cancer Inst 1997;89:1782-8.
33. Videtic GM, Truong PT, Ash RB, et al. Does sex influence the impact that smoking, treatment interruption and impaired pulmonary function have on outcome in limited stage small cell lung cancer treatment? Can Respir J 2005;12:245-50.
34. Walker MS, Vidrine DJ, Gritz ER, et al. Smoking relapse during the first year after treatment for early-stage non-small-cell lung cancer. Cancer Epidemiol Biomarkers Prev 2006;15:2370-7.
35. Zhang Q, Tang X, Zhang ZF, et al. Nicotine induces hypoxia-inducible factor-1alpha expression in human lung cancer cells via nicotinic acetylcholine receptor-mediated signaling pathways. Clin Cancer Res 2007;13:4686-94.
36. Zhou W, Heist RS, Liu G, et al. Smoking cessation before diagnosis and survival in early stage non-small cell lung cancer patients. Lung Cancer 2006;53:375-80.